The Moncton Hospital is a Canadian hospital in Moncton, New Brunswick. The Moncton Hospital operates as a tertiary care referral hospital for New Brunswick, as well as neighbouring regions of northeastern Nova Scotia and the province of Prince Edward Island.

There are 381 beds in The Moncton Hospital.

During the past decade, The Moncton Hospital conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 39 clinical trials were completed, i.e. on average, 84.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 23 clinical trials were completed. i.e. 143.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Moncton Hospital" #1 sponsor was "NCIC Clinical Trials Group" with 22 trials, followed by "National Cancer Institute (NCI)" with 13 trials sponsored, "Canadian Cancer Trials Group" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "Hoffmann-La Roche" with 6 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Moncton Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "North Central Cancer Treatment Group" with 7 trials as a collaborator. Other collaborators include 130 different institutions and companies that were collaborators in the rest 95 trials.

According to Clinical.Site data, the most researched conditions in "The Moncton Hospital" are "Breast Cancer" (15 trials), "Lymphoma" (9 trials), "Colorectal Cancer" (6 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (5 trials) and "Lung Cancer" (4 trials). Many other conditions were trialed in "The Moncton Hospital" in a lesser frequency.

Most popular intervention types in "The Moncton Hospital" are "Drug" (88 trials), "Other" (27 trials), "Biological" (24 trials), "Procedure" (15 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Laboratory Biomarker Analysis" (9 trials), "Pembrolizumab" (9 trials), "prednisone" (8 trials) and "rituximab" (8 trials). Other intervention names were less common.

The vast majority of trials in "The Moncton Hospital" are 90 trials for "All" genders, 20 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "The Moncton Hospital". undefined are not yet recruiting, 9 are recruiting, 25 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 68 completed trials in The Moncton Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in The Moncton Hospital, 1 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".